For example, the caspase-1 inhibitor AC-YVAD-CMK suppresses NOD-like receptor protein 1 (NLRP1) inflammasome activation and decreases IL-1β and IL-18 expression, alleviating sepsis-induced AKI in mice [133]. Here, IL18 is linked to acute kidney injury.